In vivo genetic manipulation of inner ear connexin expression by bovine adeno-associated viral vectors

被引:0
作者
Giulia Crispino
Fabian Galindo Ramirez
Matteo Campioni
Veronica Zorzi
Mark Praetorius
Giovanni Di Pasquale
John A. Chiorini
Fabio Mammano
机构
[1] Foundation for Advanced Biomedical Research,Venetian Institute of Molecular Medicine
[2] University of Padua,Department of Physics and Astronomy “G. Galilei”
[3] Institute of Cell Biology and Neurobiology,Department of Biomedical Sciences
[4] Italian National Research Council,Department of Otolaryngology
[5] University of Heidelberg Medical Center,Molecular Physiology and Therapeutics Branch
[6] National Institute of Dental and Craniofacial Research,Shanghai Institute for Advanced Immunochemical Studies
[7] National Institutes of Health,Physiology Institute
[8] ShanghaiTech University,Department of Biochemistry and Biotechnology
[9] Autonomous University of Puebla,undefined
[10] University of Pavia,undefined
来源
Scientific Reports | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We have previously shown that in vitro transduction with bovine adeno–associated viral (BAAV) vectors restores connexin expression and rescues gap junction coupling in cochlear organotypic cultures from connexin–deficient mice that are models DFNB1 nonsyndromic hearing loss and deafness. The aims of this study were to manipulate inner ear connexin expression in vivo using BAAV vectors, and to identify the optimal route of vector delivery. Injection of a BAAV vector encoding a bacterial Cre recombinase via canalostomy in adult mice with floxed connexin 26 (Cx26) alleles promoted Cre/LoxP recombination, resulting in decreased Cx26 expression, decreased endocochlear potential, increased hearing thresholds, and extensive loss of outer hair cells. Injection of a BAAV vector encoding GFP-tagged Cx30 via canalostomy in P4 mice lacking connexin 30 (Cx30) promoted formation of Cx30 gap junctions at points of contacts between adjacent non-sensory cells of the cochlear sensory epithelium. Levels of exogenous Cx30 decayed over time, but were still detectable four weeks after canalostomy. Our results suggest that persistence of BAAV-mediated gene replacement in the cochlea is limited by the extensive remodeling of the organ of Corti throughout postnatal development and associated loss of non-sensory cells.
引用
收藏
相关论文
共 193 条
[31]  
Patuzzi R(1993)Reverse transduction measured in the isolated cochlea by laser Michelson interferometry Nature 81 1305-388
[32]  
Wangemann P(2001)Mechanics of the mammalian cochlea Physiological reviews 21 159-563
[33]  
Liu J(1998)How well do we understand the cochlea? Trends Neurosci 88 173-98
[34]  
Marcus DC(2008)Cochlear outer hair cell motility Physiological reviews 161 377-1123
[35]  
Adachi N(2012)Virus-mediated gene delivery for human gene therapy J Control Release 24 556-585
[36]  
Beurg M(2016) CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa Molecular therapy: the journal of the American Society of Gene Therapy 66 87-334
[37]  
Goldring AC(2009)Adenoviral and AAV-mediated gene transfer to the inner ear: role of serotype, promoter, and viral load on Advances in oto-rhino-laryngology 20 1119-390
[38]  
Ricci AJ(2013) and Gene therapy 4 575-105
[39]  
Fettiplace R(2001) infection efficiencies Molecular therapy: the journal of the American Society of Gene Therapy 7 324-2564
[40]  
Wu Z(2002)Gene therapy for deafness Audiology & neuro-otology 19 384-335